123 related articles for article (PubMed ID: 38335758)
21. Interleukin 4 inhibits IL-2-induced proliferation of a human T-leukemia cell line without interfering with p56-LCK kinase activation.
Torigoe T; O'Connor R; Fagard R; Fischer S; Santoli D; Reed JC
Cytokine; 1992 Sep; 4(5):369-76. PubMed ID: 1420998
[TBL] [Abstract][Full Text] [Related]
22. The SH3 domains of the protein kinases ITK and LCK compete for adjacent sites on T cell-specific adapter protein.
Andersen TCB; Kristiansen PE; Huszenicza Z; Johansson MU; Gopalakrishnan RP; Kjelstrup H; Boyken S; Sundvold-Gjerstad V; Granum S; Sørli M; Backe PH; Fulton DB; Karlsson BG; Andreotti AH; Spurkland A
J Biol Chem; 2019 Oct; 294(42):15480-15494. PubMed ID: 31484725
[TBL] [Abstract][Full Text] [Related]
23. De novo phosphorylation and conformational opening of the tyrosine kinase Lck act in concert to initiate T cell receptor signaling.
Philipsen L; Reddycherla AV; Hartig R; Gumz J; Kästle M; Kritikos A; Poltorak MP; Prokazov Y; Turbin E; Weber A; Zuschratter W; Schraven B; Simeoni L; Müller AJ
Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096507
[TBL] [Abstract][Full Text] [Related]
24. Regulation of protein kinase Ctheta function during T cell activation by Lck-mediated tyrosine phosphorylation.
Liu Y; Witte S; Liu YC; Doyle M; Elly C; Altman A
J Biol Chem; 2000 Feb; 275(5):3603-9. PubMed ID: 10652356
[TBL] [Abstract][Full Text] [Related]
25. A weak Lck tail bite is necessary for Lck function in T cell antigen receptor signaling.
Nika K; Tautz L; Arimura Y; Vang T; Williams S; Mustelin T
J Biol Chem; 2007 Dec; 282(49):36000-9. PubMed ID: 17897955
[TBL] [Abstract][Full Text] [Related]
26. The kinase Itk and the adaptor TSAd change the specificity of the kinase Lck in T cells by promoting the phosphorylation of Tyr192.
Granum S; Sundvold-Gjerstad V; Gopalakrishnan RP; Berge T; Koll L; Abrahamsen G; Sørlie M; Spurkland A
Sci Signal; 2014 Dec; 7(355):ra118. PubMed ID: 25492967
[TBL] [Abstract][Full Text] [Related]
27. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
[TBL] [Abstract][Full Text] [Related]
28. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
29. Novel Targeted Photosensitizer as an Immunomodulator for Highly Efficient Therapy of T-Cell Acute Lymphoblastic Leukemia.
Yuan G; Yao M; Lv H; Jia X; Chen J; Xue J
J Med Chem; 2020 Dec; 63(24):15655-15667. PubMed ID: 33300796
[TBL] [Abstract][Full Text] [Related]
30. Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cells.
Bondzi C; Litz J; Dent P; Krystal GW
Cell Growth Differ; 2000 Jun; 11(6):305-14. PubMed ID: 10910097
[TBL] [Abstract][Full Text] [Related]
31. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
Nyakeriga AM; Garg H; Joshi A
Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
[TBL] [Abstract][Full Text] [Related]
32. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
[TBL] [Abstract][Full Text] [Related]
33. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
Mahabeleshwar GH; Das R; Kundu GC
J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
[TBL] [Abstract][Full Text] [Related]
34. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase.
Yu CL; Jove R; Burakoff SJ
J Immunol; 1997 Dec; 159(11):5206-10. PubMed ID: 9548458
[TBL] [Abstract][Full Text] [Related]
35. Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
Vahedi S; Chueh FY; Dutta S; Chandran B; Yu CL
Oncol Rep; 2015 Jul; 34(1):43-50. PubMed ID: 25997448
[TBL] [Abstract][Full Text] [Related]
36. The Src tyrosine kinase Lck binds to CD2, CD4-1, and CD4-2 T cell co-receptors in channel catfish, Ictalurus punctatus.
Taylor EB; Wilson M; Bengten E
Mol Immunol; 2015 Aug; 66(2):126-38. PubMed ID: 25771179
[TBL] [Abstract][Full Text] [Related]
37. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
Krystal GW; DeBerry CS; Linnekin D; Litz J
Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases.
Hurley TR; Hyman R; Sefton BM
Mol Cell Biol; 1993 Mar; 13(3):1651-6. PubMed ID: 8441403
[TBL] [Abstract][Full Text] [Related]
39. Roles of Lck, Syk and ZAP-70 tyrosine kinases in TCR-mediated phosphorylation of the adapter protein Shc.
Walk SF; March ME; Ravichandran KS
Eur J Immunol; 1998 Aug; 28(8):2265-75. PubMed ID: 9710204
[TBL] [Abstract][Full Text] [Related]
40. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
Zhu X; Kim JL; Newcomb JR; Rose PE; Stover DR; Toledo LM; Zhao H; Morgenstern KA
Structure; 1999 Jun; 7(6):651-61. PubMed ID: 10404594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
